Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T13:35:38.975Z.
Calculation as of: 2026-10-06T13:35:38.975Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 533c4696450707580a389d0c8167e09da333cd728c1767827588ef029f48caf5
EARNINGS YIELD
N/A
Market Cap
$1.38B
Earnings Yield
N/A
TTM Avg
818.17%
3Y Avg
818.17%
5Y Avg
818.17%
Market Cap
$1.42B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.23B
Earnings Yield
N/A
TTM Avg
1.54%
3Y Avg
1.54%
5Y Avg
1.54%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | $1.33B | N/A | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.34B | N/A | N/A | N/A | N/A |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.35B | N/A | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.38B | N/A | 818.17% | 818.17% | 818.17% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.42B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.23B | N/A | 1.54% | 1.54% | 1.54% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 5.54% | 3.84% | 4.37% | 4.37% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
